share_log

Jefferies Maintains Hold on Moderna, Raises Price Target to $250

Benzinga Real-time News ·  Jul 15, 2021 09:50

Jefferies analyst Michael Yee maintains Moderna (NASDAQ:MRNA) with a Hold and raises the price target from $170 to $250.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment